Publications by authors named "Peter A Tauber"

Claim this Profile
S
Severe COVID-19 induces prolonged elevation of the acute-phase protein pentraxin 3.
Bernhard Kratzer, Robert B Stieger, Seyma Durmus, Doris Trapin, Pia Gattinger, Peter A Tauber

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19.
Bernhard Kratzer, Pia Gattinger, Peter A Tauber, Mirjam Schaar, Al Nasar Ahmed Sehgal

Int J Mol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19.
Bernhard Kratzer, Pia Gattinger, Doris Trapin, Paul Ettel, Ulrike Körmöczi, Peter A Tauber

Allergy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024.
Al Nasar Ahmed Sehgal, Peter A Tauber, Robert B Stieger, Bernhard Kratzer, Winfried F Pickl

Int Arch Allergy Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4 T cells resembling iTreg.
Peter A Tauber, Bernhard Kratzer, Philipp Schatzlmaier, Ursula Smole, Cordula Köhler

Front Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV-2-specific immune response.
Bernhard Kratzer, Larissa C Schlax, Pia Gattinger, Petra Waidhofer-Söllner, Doris Trapin, Peter A Tauber

Allergy· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes.
Pia Gattinger, Katarzyna Niespodziana, Karin Stiasny, Sabina Sahanic, Inna Tulaeva, Peter A Tauber

Allergy· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1.
Oluwatoyin Akinfenwa, Huey-Jy Huang, Birgit Linhart, Margarete Focke-Tejkl, Susanne Vrtala, Peter Anton Tauber

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
Bernhard Kratzer, Doris Trapin, Paul Ettel, Ulrike Körmöczi, Arno Rottal, Peter A Tauber

Allergy· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity.
Ursula Smole, Naina Gour, Jordan Phelan, Gerhard Hofer, Cordula Köhler, Peter A Tauber

Nat Immunol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The making and function of CAR cells.
Maja Zabel, Peter A Tauber, Winfried F Pickl

Immunol Lett· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological targeting of allergen-specific T lymphocytes.
Peter A Tauber, Winfried F Pickl

Immunol Lett· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis